University of Iowa Health Care researchers have started a new clinical trial to determine if plasma from recovered COVID-19 patients can help treat patients currently hospitalized with the disease. The key to this “convalescent plasma” approach is the antibodies produced in people when they fight off COVID-19. These so-called neutralizing antibodies can be collected in plasma donations from the recovered patients and transfused into hospitalized patients with the goal of helping those patients fight the disease more effectively. The study has started taking plasma donations and, so far, 11 recovered patients have donated plasma and five patients have received the plasma transfusions as part of their care for COVID-19. The donation process takes about 90 minutes. Individuals interested in more information about donating should contact PathologyCP@healthcare.uiowa.edu, or call 319-678-7922.